a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, VIR has been loosely correlated with CRSP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then CRSP could also see price increases.
Ticker / NAME | Correlation To VIR | 1D Price Change % | ||
---|---|---|---|---|
VIR | 100% | -2.92% | ||
CRSP - VIR | 52% Loosely correlated | -1.85% | ||
TECH - VIR | 51% Loosely correlated | +2.04% | ||
QSI - VIR | 47% Loosely correlated | +2.06% | ||
AVIR - VIR | 47% Loosely correlated | +0.60% | ||
NTLA - VIR | 46% Loosely correlated | -3.24% | ||
More |